Alexion has Long-term Upside, But the Ride will be Bumpy
I would note that the title I submitted to Seeking Alpha editors was
"Alexion Pharmaceuticals: What to look for in 2016 and Beyond"
I don't have much ALXN in my portfolio, I bought a minimal amount in February 2015 at $175.12 per share. It went well up for a while, now I am down. So I am seriously thinking of buying more Alexion at bargain prices. On the other hand, my cash is limited, and there are other companies that are competing for that cash use. I may even just hold onto the cash for a clearer short-term opportunity.